Azithromycin has a uniquely prolonged tissue half-life of approximately 68 hours compared to clarithromycin (~5 hours). This pharmacokinetic difference is primarily due to:
- A Azithromycin undergoes extensive lysosomal trapping in phagocytes (large tissue distribution, Vd ~31 L/kg), achieving high intracellular concentrations, and is slowly released, while clarithromycin distributes more evenly ✓
- B Azithromycin is more extensively metabolized by CYP3A4 than clarithromycin, producing a longer-acting active metabolite
- C Azithromycin binds irreversibly to bacterial ribosomes causing bactericidal action that sustains post-antibiotic effect
- D Azithromycin undergoes enterohepatic recirculation that extends its plasma half-life
Correct answer: A. Azithromycin undergoes extensive lysosomal trapping in phagocytes (large tissue distribution, Vd ~31 L/kg), achieving high intracellular concentrations, and is slowly released, while clarithromycin distributes more evenly
Explanation
Azithromycin is a basic, amphiphilic molecule that concentrates extensively in lysosomes of phagocytes (neutrophils, macrophages) by pH-trapping (lysosomal pH ~5.0 protonates the drug, preventing efflux), resulting in intracellular-to-extracellular concentration ratios of >100:1 and a very large volume of distribution (~31 L/kg). This tissue depot is slowly released over days, giving an effective tissue half-life of 68 hours; this supports once-daily dosing and 3-day courses. Clarithromycin does not achieve equivalent tissue accumulation.
Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.